Prospective cohort study observes transient intraocular pressure elevation after pharmacologic pupil dilation in pigment dispersion syndrome, suggesting standard mydriasis is generally safe.
This study investigates the characteristics of intraocular pressure (IOP) fluctuations in Chinese patients with pigment dispersion syndrome (PDS) after drug-induced mydriasis. In this prospective cohort study, 26 PDS patients were identified and instilled with 0.5% tropicamide and phenylephrine twice randomly in one of the 2 eyes, after which IOP and pupil diameter (PD) were measured hourly for 8 hours. A slit-lamp examination was performed after each measurement. Post-mydriatic IOPs and PDs were compared with baseline. The average IOP increased to a maximum of 18.3 ± 4.9 mm Hg (vs 16.7 ± 4.5 mm Hg at baseline; P = .002) 1 hour after dilation. Accordingly, the PD reached its peak (8.3 ± 0.6 mm vs 5.9 ± 1.0 mm; P < .001). By the end of the 8-hour observation period, mean IOP had decreased to 17.4 mm Hg and mean PD to 7.1 mm. The majority of these eyes (88.5%, 23/26) exhibited mild IOP elevation of 2.5 ± 1.4 mm Hg (range: 0–4.9 mm Hg). In the non-laser peripheral iridotomy group, 2 eyes (13.3%, 2/15) developing moderate anterior chamber pigment shedding showed an increase in IOP of ≥ 5 mm Hg after dilation (21.1 and 12.6 mm Hg); 1 eye (9.1%, 1/11) receiving laser peripheral iridotomy showed a similar IOP increase (5.1 mm Hg). All clinically significant IOP elevations were resolved without treatment. No post-mydriatic IOP ≥ 40 mm Hg was detected during the study. Drug-induced mydriasis appears relatively safe in the majority of Chinese PDS patients, with generally mild effect in most. However, caution remains warranted in eyes with prominent anterior chamber pigment shedding.
No takes yet. Share an insight, caveat, or question.
Pu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: